COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
This webinar has been initiated and commissioned by Intercept Pharma UK and Ireland Ltd and organised in partnership with Guidelines. Intercept Pharma UK and Ireland Ltd has reviewed the scope of the webinar, commissioned the speakers, and approved all materials related to the webinar. The speakers have been paid an ...